NYCB

Analyst Note: NYCB (New York Community Bancorp, Inc.)

Date: 2026-06-13 Current Price: $10.55

1. Structural Readiness

• Conservative Entry: Not applicable (Breakout has not fired).
• Aggressive/Pre-Breakout Entry: Not applicable (Setup is forming, not confirmed).
• Breakout Level: Not yet established.
• Current Price: $10.55.
• Extension: Not applicable (No breakout to measure extension from).
• ATR Context: Current ATR is 5.2% (High). This indicates elevated volatility, which is within the historical "sweet spot" (4–6%) for structural setups, suggesting sufficient price movement to test levels but not yet in the "extreme" (>8%) danger zone for severe losers.

2. Thesis Layer

• Thesis Classification: Tactical, Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the immediate business fundamentals (loan growth, asset quality, capital return). No macro narratives should be invented to support the position.

3. Business Overview

• Company Profile: New York Community Bancorp, Inc. operates as the bank holding company for New York Community Bank. It provides a comprehensive suite of banking products and financial services across Metro New York, New Jersey, Ohio, Florida, and Arizona.
• Operations: The institution operates through a network of 237 branches and 333 ATM locations, serving individuals, small-to-mid-sized businesses, and professional associations.
• Product Mix:
• Deposits: Interest-bearing checking, money market, savings, non-interest-bearing accounts, IRAs, and CDs.
• Loans: The portfolio includes multi-family, commercial real estate (CRE), specialty finance, commercial and industrial (C&I), acquisition/development/construction (ADC), one-to-four family residential, and consumer loans.
• Other: Annuities, life/long-term care insurance, mutual funds, and cash management products.
• Recent Business Performance (as of Q1 2026 Earnings, 2026-04-24):
• Loan Growth: C&I loans grew by $1.4 billion (9%) on a linked-quarter basis, described as "significantly higher than in prior quarters."
• Pipeline: Management expects second-quarter C&I fundings to be similar to Q1, citing a "strong pipeline."
• Asset Quality: The bank has reduced exposure to certain industries and exited relationships that did not meet return hurdles. This marks the third consecutive quarter of C&I loan growth following these risk reductions.
• Non-Performing Assets (NPA): Management has set a goal to reduce nonperforming assets to $2 billion by the end of 2026.
• Net Interest Margin (NIM): Expanded 10 basis points after adjusting for a one-time hedge gain of approximately $21 million in Q4.
• Capital Returns: Management expects the Board to take action on capital distributions (dividends/buybacks) in the second half of 2026.

4. Archetype and Conviction

• Archetype: Growth Leader (with elements of Deep Value Recovery).
• *Fit:* The name fits "Growth Leader" due to the accelerating C&I loan growth ($1.4B in one quarter) and the explicit guidance for total asset expansion to $94B by end-2026 and $102B by end-2027. Simultaneously, the focus on reducing NPAs and exiting poor-return relationships suggests a recovery from a prior distressed state.
• Valuation Context:
• Forward consensus EPS (FY1) is $0.95898.
• Management guidance for Adjusted EPS is $0.60–$0.65 for 2026 and $1.80–$1.90 for 2027.
• *Note:* The current price of $10.55 implies a forward P/E of roughly 11x based on FY1 consensus, or a significant multiple compression relative to the 2027 guidance if the growth trajectory holds.
• Conviction Stack:
• Thesis Strength: Low (No macro thesis; purely tactical).
• Evidence Quality: High (Strong earnings transcript data, clear management guidance on asset growth and NPA reduction).
• Structural Quality: Moderate (ATR of 5.2% is healthy; setup is "forming" rather than "confirmed").
• Rerating Potential: Moderate (Dependent on successful NPA reduction and capital return execution).

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the resistance level (breakout firing) accompanied by volume, or a specific announcement confirming the capital distribution in the second half of the year ahead of schedule.
• Evidence Gaps:
• Breakout Confirmation: No evidence of a breakout event has occurred as of 2026-06-13.
• NPA Current Level: While the *goal* ($2B) is stated, the *current* NPA level as of June 2026 is not explicitly quantified in the provided text, only the trajectory.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: C&I loans grew $1.4B (9%) in Q1 2026; Management targets $2B NPA by year-end; Asset growth guidance to $94B in 2026 and $102B in 2027; Capital distributions expected in H2 2026. Key risks: Setup is "forming" not "confirmed" (breakout not fired); High volatility (5.2% ATR) increases risk of false breakouts; NPA reduction target is aggressive and execution risk exists; No named secular thesis to support valuation rerating. Sizing hint: Position size should be reduced relative to a confirmed breakout setup due to the "forming" status and lack of macro tailwinds. Expected horizon: 3 to 6 months (through H2 2026 capital actions).